Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in Uterine Sarcoma.
Ling YangYing CaiYunjia WangYue HuangChi ZhangHu MaJian-Guo ZhouPublished in: Technology in cancer research & treatment (2024)
FGF23 was highly expressed in US and was promising as a novel potential biomarker for the diagnosis and prognosis of US.
Keyphrases